<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02458027</url>
  </required_header>
  <id_info>
    <org_study_id>B2014:115-3</org_study_id>
    <nct_id>NCT02458027</nct_id>
  </id_info>
  <brief_title>A FINEH Protein Trial - Part 2</brief_title>
  <official_title>Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2 - Are Acute Effects of Hemp Protein on Blood Glucose and Appetite Insulin-dependent?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Manitoba Harvest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this trial are to investigate whether the effects of hemp protein on
      glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin
      and appetite for one hour following consumption, 2) blood glucose, insulin and appetite
      following a fixed energy meal to determine the &quot;second meal effect&quot; of hemp protein versus
      soybean protein and a non-protein control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">July 13, 2016</completion_date>
  <primary_completion_date type="Actual">July 13, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Glucose and Insulin Concentrations</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured in blood using intravenous catheter at 12 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appetite</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured by VAS Questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Food Intake</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured by fixed energy meal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured by automated bood pressure cuff.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Palatability of Treatments and Meal</measure>
    <time_frame>5-80 minutes</time_frame>
    <description>Measured by VAS Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Comfort</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured by VAS Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy/Fatigue</measure>
    <time_frame>0-200 minutes</time_frame>
    <description>Measured by VAS Questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Diabetes Prevention</condition>
  <condition>Obesity Prevention</condition>
  <arm_group>
    <arm_group_label>20g Hemp Protein Shake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemp protein shake, 20 grams, given once at beginning of acute trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40 g Hemp Protein Shake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemp protein shake, 40 grams, given once, at beginning of acute trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 g Soybean Protein Shake</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Soybean protein shake, 20 grams, given once, at beginning of acute trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40 g Soybean Protein Shake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Soybean protein shake, 40 grams, given once, at beginning of acute trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Shake</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-protein control shake, given once, at beginning of acute trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hemp Shake</intervention_name>
    <description>Hemp Protein Shake</description>
    <arm_group_label>20g Hemp Protein Shake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hemp Shake</intervention_name>
    <description>Hemp Protein Shake</description>
    <arm_group_label>40 g Hemp Protein Shake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soybean Shake</intervention_name>
    <description>Soybean Protein Shake</description>
    <arm_group_label>20 g Soybean Protein Shake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soybean Shake</intervention_name>
    <description>Soybean Protein Shake</description>
    <arm_group_label>40 g Soybean Protein Shake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Non-Protein Shake</description>
    <arm_group_label>Control Shake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normoglycemic (&lt;5.6 mmol/L)

          -  Body mass index (BMI) of 18.5-29.9 kg/m2.

        Exclusion Criteria:

          -  Restrained eaters

          -  Regularly skip breakfast

          -  Smokers

          -  Those on medications that may influence study outcomes or have experienced any
             gastrointestinal related health conditions/surgeries over the past year.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Jones, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Richardson Centre for Functional Foods and Nutraceuticals</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>May 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2015</study_first_posted>
  <last_update_submitted>August 28, 2018</last_update_submitted>
  <last_update_submitted_qc>August 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

